Atria Wealth Solutions Inc. Sells 23,615 Shares of The Clorox Company $CLX

Key Points

• Atria Wealth Solutions Inc. reduced its stake in The Clorox Company by 70.6%, selling 23,615 shares, and now holds 9,822 shares valued at approximately $1.18 million.
• Several institutional investors have adjusted their positions in Clorox, with notable increases from Sumitomo Mitsui DS Asset Management and American National Bank & Trust, which boosted its stake by 69.5% in the second quarter.
• Analysts have differing views on Clorox's stock outlook, with Barclays downgrading its price target from $118 to $112, while Zacks upgraded its rating from "strong sell" to "hold".

Atria Wealth Solutions Inc. lessened its position in The Clorox Company (NYSE:CLX - Free Report) by 70.6% during the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 9,822 shares of the company's stock after selling 23,615 shares during the period. Atria Wealth Solutions Inc.'s holdings in Clorox were worth $1,184,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Sumitomo Mitsui DS Asset Management Company Ltd raised its position in shares of Clorox by 0.6% during the 1st quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 13,266 shares of the company's stock valued at $1,953,000 after purchasing an additional 73 shares during the period. Horizon Investments LLC increased its stake in Clorox by 4.4% in the 1st quarter. Horizon Investments LLC now owns 1,768 shares of the company's stock worth $258,000 after buying an additional 75 shares in the last quarter. Sfmg LLC raised its holdings in Clorox by 2.8% during the first quarter. Sfmg LLC now owns 2,780 shares of the company's stock valued at $409,000 after acquiring an additional 76 shares during the period. Hancock Whitney Corp lifted its position in shares of Clorox by 4.3% in the first quarter. Hancock Whitney Corp now owns 2,064 shares of the company's stock valued at $304,000 after acquiring an additional 86 shares in the last quarter. Finally, American National Bank & Trust boosted its stake in shares of Clorox by 69.5% in the second quarter. American National Bank & Trust now owns 217 shares of the company's stock worth $26,000 after acquiring an additional 89 shares during the period. Institutional investors own 78.53% of the company's stock.

Wall Street Analyst Weigh In

A number of research analysts recently commented on CLX shares. Barclays lowered their price target on Clorox from $118.00 to $112.00 and set an "underweight" rating on the stock in a report on Tuesday, September 30th. Weiss Ratings reiterated a "hold (c-)" rating on shares of Clorox in a research report on Tuesday. UBS Group dropped their target price on shares of Clorox from $134.00 to $128.00 and set a "neutral" rating for the company in a research report on Wednesday, October 8th. The Goldman Sachs Group reduced their price target on shares of Clorox from $115.00 to $110.00 and set a "sell" rating on the stock in a report on Wednesday, October 1st. Finally, Zacks Research upgraded shares of Clorox from a "strong sell" rating to a "hold" rating in a research note on Monday, September 29th. One analyst has rated the stock with a Buy rating, twelve have given a Hold rating and three have given a Sell rating to the company. According to data from MarketBeat, the company currently has an average rating of "Reduce" and a consensus target price of $131.64.

Insiders Place Their Bets

In other Clorox news, COO Eric H. Reynolds sold 15,041 shares of the business's stock in a transaction on Thursday, September 4th. The shares were sold at an average price of $123.78, for a total transaction of $1,861,774.98. Following the transaction, the chief operating officer owned 54,221 shares in the company, valued at $6,711,475.38. The trade was a 21.72% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. 0.63% of the stock is owned by company insiders.

Clorox Stock Performance

Clorox stock opened at $117.66 on Friday. The company's 50-day moving average price is $121.71 and its 200-day moving average price is $128.06. The Clorox Company has a twelve month low of $116.53 and a twelve month high of $171.37. The company has a quick ratio of 0.57, a current ratio of 0.84 and a debt-to-equity ratio of 5.15. The company has a market cap of $14.33 billion, a PE ratio of 18.05, a price-to-earnings-growth ratio of 0.98 and a beta of 0.52.

Clorox (NYSE:CLX - Get Free Report) last posted its earnings results on Thursday, July 31st. The company reported $2.87 earnings per share for the quarter, topping analysts' consensus estimates of $2.24 by $0.63. Clorox had a net margin of 11.40% and a return on equity of 377.86%. The firm had revenue of $1.99 billion for the quarter, compared to the consensus estimate of $1.94 billion. During the same period in the previous year, the firm posted $1.82 EPS. The business's quarterly revenue was up 4.5% on a year-over-year basis. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. On average, equities research analysts forecast that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, November 6th. Stockholders of record on Wednesday, October 22nd will be given a dividend of $1.24 per share. The ex-dividend date of this dividend is Wednesday, October 22nd. This represents a $4.96 annualized dividend and a dividend yield of 4.2%. Clorox's payout ratio is currently 76.07%.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.